Track topics on Twitter Track topics that are important to you
Innovative research and partnerships are delivering us, for the first time, substantially shorter and safer drug treatments for tuberculosis. The challenge now is ensure these new drugs reach those who need them the most.
Original Article: Better Therapies For TB Are Here, But They Will Not Deliver ThemselvesNEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. Over nine million new cases of TB, and nearly two million deaths from TB, are estimated to occur around the world every year, and new inf...